Company or institution

GLAXOSMITHKLINE LLC

Save Like

383 applicationsfiled 2006 to 2026

Allowance rate

63%

−12 pts vs the USPTO range 58% to 68%

Rejections before allowance

1.3

−0.3 vs the USPTO

Months to first action

11.6 mo

−7.0 vs the USPTO

Needed an RCE

26%

−2 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds177 apps

A61K Medical preparations139 apps

C07K Peptides16 apps

C07H 10 apps

C07C 8 apps

A61P Therapeutic activity of compounds7 apps

Art units

162487 apps

162652 apps

162541 apps

162229 apps

162823 apps

162716 apps

Examiners met

The examiners seen most, and how it went with each

Deepak R Rao15 apps

73%

Rebecca L Anderson15 apps

93%

Emily A Bernhardt12 apps

50%

Brian E McDowell11 apps

55%

Kristin Ann Vajda10 apps

70%

Jeffrey H Murray9 apps

67%

Brenda Libby Coleman9 apps

56%

Timothy R Rozof9 apps

89%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

GlaxoSmithKline340 apps

62%

FISH & RICHARDSON P.C. (TC)10 apps

90%

NOVARTIS PHARMACEUTICAL CORPORATION8 apps

50%

WOLF GREENFIELD & SACKS, P.C.5 apps

100%

DORITY & MANNING, P.A.4 apps

Morgan, Lewis & Bockius LLP (SF)3 apps

33%

Ruggiero McAllister & McMahon LLC - GSK3 apps

100%

MCCARTER & ENGLISH, LLP BOSTON2 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19542895	PLATELET COUNT-AGNOSTIC METHODS OF TREATING MYELOFIBROSIS	2026-02-18	Pending	0	0	n/a
19459164	Phenyl Amino Pyrimidine Compounds and Uses Thereof	2026-01-26	Pending	0	0	n/a
18602258	PLATELET COUNT-AGNOSTIC METHODS OF TREATING MYELOFIBROSIS	2024-03-12	Allowed	1	0	6.2 mo
15694999	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15245586	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15303659	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15915921	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15927993	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15529924	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15861957	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 383 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in